Verapamil in Supraclavicular Brachial Plexus Block

Study Overview
=================
Brief Summary
-----------------
Supraclavicular brachial plexus block (SCBPB) is the common approach to provide surgical anesthesia of upper limb. The effects of single-injection brachial plexus nerve blocks recede after several hours unmasking the moderate to- severe pain of the surgical insult.

Detailed Description
-----------------
Strategies to prolong brachial plexus nerve blocks analgesia beyond the pharmacological duration of the local anaesthetic used include placement of indwelling perineural catheters to allow prolonged infusion or the co-administration of adjuvants such as epinephrine, a2 agonists (i.e. clonidine and dexmedetomidine), midazolam, or the corticosteroid dexamethasone. The investigators will use calcium channel blocker as adjuvant to bupivacaine in supraclavicular block. Calcium plays an important role in analgesia produced by local anesthetics. The activation of N-methyl-D-aspartate receptors may lead to calcium entry into cells and potentiation of spinal cord and plays a role in pain formation. Hence, calcium channel blockers may prevent central sensitization and provide better sensory motor block characteristics. Verapamil, a calcium channel blocker can potentiate analgesic action of local anesthetics and reduce postoperative pain and analgesic consumption. Few studies were there using 2.5 mg of verapamil, showing no effect on onset and duration of sensory motor block. Hence, the investigators have used 5 mg of verapamil as adjuvant to bupivacaine. The primary aim of the study was to know whether verapamil (5 mg) as adjuvant to bupivacaine in supraclavicular brachial plexus block would delay the need of rescue analgesia.

Official Title
-----------------
Effect of Verapamil as an Adjuvant to Bupivacaine in Supraclavicular Brachial Plexus Block Guided by Ultrasound for Forearm and Hand Surgeries

Conditions
-----------------
Regional Anesthesia Morbidity

Intervention / Treatment
-----------------
* Diagnostic Test: complete blood count
* Diagnostic Test: prothrombin time
* Diagnostic Test: prothrombin concentration
* Drug: Verapamil


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: ASA I-II patients older than 18years and scheduled for forearm and hand surgeries like : fracture radius and ulna. cut wrists. Exclusion Criteria: allergy to the study drugs, skin infection at site of needle puncture, significant organ dysfunction, coagulopathy, drug or alcohol abuse, epilepsy, and psychiatric illness that would interfere with perception and assessment of pain.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 60 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Other
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Single


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Placebo Comparator: Group (A) : 30 patients (control group):<br>Patient will receive 20 to 30 ml bupivacaine plus 2 ml of normal saline . | Diagnostic Test: complete blood count<br>* laboratory test<br>Diagnostic Test: prothrombin time<br>* laboratory test<br>Diagnostic Test: prothrombin concentration<br>* laboratory test<br>|
| Experimental: Group (B) : 30 patients (verapamil group):<br>Patient will receive 20 to 30 ml bupivacaine plus 5 mg of verapamil diluted in 2 ml of normal saline. | Diagnostic Test: complete blood count<br>* laboratory test<br>Diagnostic Test: prothrombin time<br>* laboratory test<br>Diagnostic Test: prothrombin concentration<br>* laboratory test<br>Drug: Verapamil<br>* drug will be add to prolong the effect of regional block<br>* Other names: Isoptin;|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| duration of postoperative analgesia. | blinded observer will collect the Visual Analogue Score (VAS) for pain scored from Zero to ten where 0= no pain and 10 = the worst pain imaginable for acute post-operative pain. | in first 24 hours |